Current Scenario of Cancer- The Incidence of Cancer in Men

Speciality: Oncology


Speaker:

Dr. Ashish Singh | MBBS, MD, Medical Oncology, CMC

Description:

A warm welcome to all the medical professionals in this crucial session on understanding the current scenario of cancer. This presentation will provide a detailed overview of the incidence of cancer in men, focusing on prevalent trends, key risk factors, and the importance of early detection. Globally, cancer is a leading cause of death, and its burden on men varies significantly by region and lifestyle. Understanding the most common cancers that affect men, such as prostate, lung, and colorectal cancer, is essential for developing effective prevention and screening strategies.

The current landscape of cancer in men is characterized by the dominance of a few specific types. In many parts of the world, prostate cancer is the most frequently diagnosed cancer, while lung and bronchus cancer remains the leading cause of cancer-related deaths. Other common malignancies include colorectal cancer, oral cancer, and head and neck cancers, which are often linked to modifiable risk factors like tobacco use and alcohol consumption. A deeper look at the incidence data reveals geographical disparities, with certain regions showing higher rates of specific cancers due to unique environmental, genetic, and lifestyle factors.

Therefore, get an overall knowledge of the current scenario of cancer incidence in men. Listen to the webinar, led by Dr. Ashish Singh, absorb the shared knowledge on the latest trends and diagnostic advancements, and follow Hidoc for more such insightful webinar sessions.


See More Webinars @ Hidoc Webinars





Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Nearly 6 Million Deaths From Five Major Cancer Types Averted Since 1975

2.

Child Death Rates Are Rising in the U. s. ; Water Beads Warning; Cancer Studies Retracted.

3.

Interleukin-6 may boost prediction of obesity-related cancers

4.

Researchers use AI to monitor side effects of chemotherapy and support families dealing with pediatric cancer.

5.

As EGFR internalization is decreased, BUB1 controls EGFR signaling.


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot